{"retracted":false,"update":{"timestamp":1491004800000,"doi":"10.1016/j.antiviral.2017.01.019","type":"erratum"},"doi":"10.1016/j.antiviral.2016.12.002","journal":"Antiviral Research","publisher":"Elsevier BV","title":"Corrigendum to “Niclosamide inhibits lytic replication of Epstein-Barr virus by disrupting mTOR activation” [(Antivir. Res.) 138 (2017) 68–78]"}
